Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.61 | N/A |
| PEG Ratio (TTM) | -14.40 | N/A |
| P/S Ratio (TTM) | 1.27 | N/A |
| P/B Ratio (TTM) | 1.23 | N/A |
| P/FCF Ratio (TTM) | 4.20 | N/A |
| Price to 5YR AVG Earnings Ratio | 6.16 | N/A |
| Price to 5YR AVG FCF Ratio | 2.53 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.97% | N/A |
| ROE (TTM) | 11.47% | N/A |
| Net Profit Margin (TTM) | 10.97% | N/A |
| ROIC 5YR AVG | 21.10% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 33.24% | 335.61% | 203.67% |
| Revenue | 0.64% | 1.71% | 2.20% |
| Net Income | 35.10% | 381.79% | 230.02% |
| Cash Flow | 15.39% | 681.47% | 417.58% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 71.81 | N/A |
| Quick Ratio (TTM) | 71.81 | N/A |
| D/E Ratio (TTM) | 0.23 | N/A |
| Interest Coverage (TTM) | 12.82 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.89 | N/A |
| LTL to 5YR AVG FCF | 2.22 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.39% | N/A |